Share Name Share Symbol Market Type Share ISIN Share Description
Ilika Plc LSE:IKA London Ordinary Share GB00B608Z994 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -2.10 -3.33% 61.00 92,068 10:07:49
Bid Price Offer Price High Price Low Price Open Price
60.00 62.00 61.00 60.00 60.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Alternative Energy 2.26 -3.84 -2.53 96
Last Trade Time Trade Type Trade Size Trade Price Currency
14:32:56 O 14,000 61.20 GBX

Ilika (IKA) Latest News

More Ilika News
Ilika Investors    Ilika Takeover Rumours

Ilika (IKA) Discussions and Chat

Ilika Forums and Chat

Date Time Title Posts
28/6/202220:13ILIKA - Multiple Material Opportunities!4,589
13/5/202208:47Ilika - First thread635
30/3/202220:47Ilika (IKA) One to Watch on Monday 28
03/3/201819:24Ilika plc (AIM: IKA)29

Add a New Thread

Ilika (IKA) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Ilika trades in real-time

Ilika (IKA) Top Chat Posts

Ilika Daily Update: Ilika Plc is listed in the Alternative Energy sector of the London Stock Exchange with ticker IKA. The last closing price for Ilika was 63.10p.
Ilika Plc has a 4 week average price of 55.50p and a 12 week average price of 54.50p.
The 1 year high share price is 212.50p while the 1 year low share price is currently 54.50p.
There are currently 157,645,867 shares in issue and the average daily traded volume is 78,697 shares. The market capitalisation of Ilika Plc is £96,163,978.87.
kenjen1: Interest growing again in this stock. Reasons: Chart pointing to upwards swing (horneblower worth listening too) Goliath was always the crown jewel and progressing as expected. :) Stereax progress being made. This should offset some of the costs of developing Goliath The share price is a steal at these levels. Be back to above a pound end of summer.
horneblower: The question is, does Ilika have a solution that will prove to be competitive in power-to-weight ratio and price? In my (worthless) opinion, knowing the individuals involved and their history, the answer is no. That is because the technology they are using is a. old hat and b. un-protected. Basically, the answer to finding a working solution to the battery problem will come from new tech, not existing. However, this does not mean that investors can't make money from Ilika shares. Many a duff company in the past has seen its shares rise profitably.
firestorm911: Was a red flag. 21/03/2022 11:45am UK Regulatory (RNS & others) Ilika (LSE:IKA) Historical Stock Chart From Mar 2022 to May 2022 Click Here for more Ilika Charts. TIDMIKA RNS Number : 4521F Ilika plc 21 March 2022 Ilika plc ("Ilika" or the "Company") Director/PDMR Shareholding Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that between 18 March and 21 March 2022, Steve Boydell, CFO, sold an aggregate of 371,222 shares at an average price of 109p per share. This completes the planned sale of shares resulting from the option exercise announced on 8 March 2022.
kenjen1: So market up Ilika down. Process qualification was due to complete end of 2021 but 5 months late? No Twitter activity and the share price continues to tank. Grand plan underway or utter incompetence?! We will soon find out.
jbgoodenough: Is owning shares in ILIKA PLC for you? The stock market is partly a mechanism for companies to raise investment funds. (Investors who invested in Ilika PLC when they floated in 2010 at 20p have made 700% on their investment). However, on a day to day basis, the stock market is a mechanism to shift ownership from weak hands to stronger hands. If your time frame for investment is short (i.e. if you thinking about being on the share register in units of less than years), Ilika is almost certainly NOT the right investment for you. (If you are a short term speculator, there are a myriad of 'investment mediums' which have higher levels of liquidity and volatility than Ilika PLC.) For those who have the patience and financial stamina to back nascent technology, Ilika PLC might be for you. If you don't have such belief in Ilika's long-standing Management team (headed by Graeme Purdy, CEO at the time of the floatation) and their equally long standing scientific team (headed by Prof. Brian Hayden, who also founded the company back in 2004), then SELL your shares and invest in things you do believe in. (This allows LTH to add at cheap prices of course). If you are a former shareholder who sold out much lower (yes, I am thinking RogK who also goes by BuzzThomas who sold out for pennies and Phil2003) why do you waste your time posting on a bulletin board about something you have no financial interest in? Please do yourselves (and everyone else) a very great favour and devote your intellect to things you do have an interest in (i.e. MOVE ON).
tomps2: Ilika Capital Markets Day. The Ilika management team, CEO Graeme Purdy, CFO Steve Boydell FCA, VP Sales & Marketing, John Tinson & VP Product Development, Robin Bell, outline the business, the market and the opportunities. Further, five partners illustrate their use of Ilika’s solid state batteries. The day ends with a tour of the facilities. This overview brings to life the scope of applications for both Stereax and Goliath and the path to commercialisation for Ilika. Video: Https:// Podcast: Https://
tp5588: Posted on another site. Credit to original poster: "Thoughts on Investor Day and Site Visit The company has changed a lot since my last site visit (pre-Covid) and is clearly gearing up for commercialisation of their world beating intellectual property. Overall, I was very impressed with progress. Ilika was founded on the back of ground breaking scientific research headed by Prof. Brian Hayden. He and his team have taken the science forward through advanced engineering (Tool 1 and Tool 2 were made bespoke to Ilika’s designs for example) towards commercial reality. My top take-away was that the Ilika’s management are now also adding focus and resources towards commerciality. Most of the traffic on bulletin boards about Ilika seems to be focussed on Goliath (batteries for EV’s). Whilst there was a very full update on Goliath progress (and a tour of the new Goliath Research and Development laboratories), which is going very well (the analysts at Liberum and Berenberg both agreed that none of the big name Goliath competitors were ahead of Ilika in terms of that technology, although they are vastly higher market valuations), I will concentrate this write up on Stereax as it will be the driver of nearer term sales revenue and seems to be less well understood. Bear in mind Ilika are in many ways creating the market through the imminent availability of Stereax batteries in quantities which will allow incorporation in commercial products. The new(ish) VP of Sales and Marketing, John Tinson was clearly out of the highest of top drawers. It was clear that Ilika are determined to nurture their client base (recall ~27 med tech device makers and 11 Internet of Things sensor makers have already been buying Ilika’s Stereax batteries for evaluation, re-certification and research and development purposes). Through his presentation and in Q&A, it was quite obvious that he understood in great detail Stereax’s market segmentation and the price inelastic nature of demand from Med Tech in particular. Tinson made clear that given the limited ability for Ilika to supply in the short term (FAB1 will be able to produce ~£13 mio worth of batteries per annum) that Ilika will be exploiting their understanding of the market for Ilika’s commercial gain. Ilika also hired another Sales VP (who also had an impressive background and who presented very well, but whose name I can’t recall – this is my lack not his; he was equally impressive as John Tinson). Through these extremely high quality hires, it is apparent that Graeme Purdy and his top management team are focussed on turning their scientific and engineering excellence into profits for the shareholders, whilst retaining a leading position in what will be a very rapidly growing market place for nano-scale batteries. As previously advised by the company (and in line with stock exchange rules) no market sensitive information was given. No doubt some PIs foolishly bought in anticipation of the investor day and are now dumping those (tiny) holdings. Frankly, I am sure that long term shareholders would rather not have such myopic people on the share register (which is now over 15% US based according to Steve Boydell CFO). Having said that, personally I think they will be announcing a full year ahead orderbook not long after product validation (which will happen after process validation, as confirmed by Paul Marron, who was clearly totally on top of the production process at FAB1). They are also currently evaluating the relative merits of increasing capacity at FAB1, bringing in-house the rest of the many processes (thinning and dicing for instance) of Stereax production and FAB2 (for which there is space next door…). Recall that the cost of FAB2 was already raised in the May 2020 fund raise (which I am glad to have taken part in). If there is an area of weakness, it was in my opinion their ham-fisted fund-raise of ~£25 mio for Goliath at a 30% discount to the prevailing market. If they needed the money (which they did; in comparison QuantumScape are making losses greater than the entire market capitalisation of Ilika in less than 3 months, every 3 months ...), they should have raised when the share price was rising above £2.75 less than 6 months earlier. This would have resulted in greater funds at lesser dilution. However, that is now in the past and the money at least has been raised and is being put to extremely efficient use. In summary, we already knew that Brian Hayden and his team were world leaders in terms of the tech (both the chemistry and in overcoming engineering problems to turn the science into commercially viable product). The shift of focus to commerciality was definitely needed, but the quality of their hiring shows just how able to evolve this Management team are. They will need to follow this up with results next financial year in terms of Sales and scale-up plans in order to continue to show their effectiveness. I am delighted with their approach of setting realistic guidance and delivering it (rather than making wild claims to gather attention, and then failing to deliver, which any student of the history of the battery industry will know it is littered with). The future looks extremely bright for long term Ilika shareholders imo."
jbgoodenough: ParkWalk Advisors are noted investors in EIS schemes. They were EIS investors in Ilika in 2018, just like they were in 2017. They have to hold the shares for 3 years to maintain the tax breaks that come with being an EIS investor. They have now satisfied that condition on those shares bought in 2018 and are taking their profits on those, just like they did in Dec 2020 at £1.00-£1.02 shortly after ROGK/BuzzThomas sold his (no doubt tiny holding) at 92p To be clear, their decision is driven by the calendar more than anything else - most of the companies they invest in do not have liquid shareholdings so they need to realise gains where they are fully qualified and exist, to show their shareholders that their EIS investments are making tangible gains (not just marked to 'model' or fantasy gains). Unlike ROGK (or BuzzThomas as he calls himself on another BB, after he was rumbled for deleting so many of his posts as ROGK which proved to be idiotic), ParkWalk Advisors have continued to hold and even buy more IKA shares (for instance in the EIS fund raising to support Goliath development earlier this year), although the absolute number of shares they now hold has declined to below 3% (i.e. the notifiable level) as a result of the sheer number of shares they were able to buy at 2018 prices which are now sold. Just like last December, there has been one dominant seller and many (smaller) buyers in recent weeks. Take a look at what happened to the price once the seller had sold what they had to last year. Meanwhile ROGK/BuzzThomas hangs around on IKA BB's perpetually trying to talk the share price down with faulty or outright false reasoning (for instance he ascribes the Parkwalk Advisor sales due to them not supporting Goliath development, when they just committed investment on a minimum 3 year basis less than 6 months ago). He seems obsessed by the company (no doubt fearing he will be the person who invested in the battery equivalent of TESLA for pennies and then sold them for pennies too ...).
phil2003: RogK is like Tom Hanks in castaway.. WILSON!! Getting more desperate as Wilson (IKA Share price) slips away from Him and the 120p where he bailed out, never to be seen again.
phil2003: AndrewBaker, All depends how you define correct price and therefore value? using Quantumscape as benchmark Llika is massively underpriced, L4L valuation means Ilika share price should be £200! Anyway, I will Continue to hold this for 10 years+
Ilika share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220629 13:57:13